Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C31H52O2
CAS Number:
Molecular Weight:
456.74
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
208-304-7
MDL number:
Beilstein/REAXYS Number:
3224721
SMILES string
[H][C@@]12CC=C3C[C@H](CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])[C@H](C)CCCC(C)C)OC(=O)CCC
assay
~95%
Looking for similar products? Visit Product Comparison Guide
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Andrea Brioschi et al.
Molecules (Basel, Switzerland), 13(2), 230-254 (2008-02-29)
Cholesterylbutyrate (Chol-but) was chosen as a prodrug of butyric acid. Butyrate is not often used in vivo because its half-life is very short and therefore too large amounts of the drug would be necessary for its efficacy. In the last
G W Han et al.
Journal of lipid research, 35(11), 2069-2082 (1994-11-01)
Cholesteryl butanoate has a complex crystal structure that differs from those of the three main structure type for cholesteryl esters. It contains four molecules (C31H52O2) unrelated by crystal symmetry. The molecules are packed in almost planar sheets and have molecular
D A Langs et al.
Acta crystallographica. Section A, Foundations of crystallography, 51 ( Pt 1), 81-87 (1995-01-01)
The shake-and-bake procedure, which is based on the minimal function, has been tested and shown to be extremely effective in molecular-fragment recycling applications. Correctly positioned fragments as small as 5% of the scattering power of the structure typically have a
R Minelli et al.
British journal of pharmacology, 166(2), 587-601 (2011-11-05)
BACKGROUND AND PURPOSE Cholesteryl butyrate solid lipid nanoparticles (cholbut SLN) provide a delivery system for the anti-cancer drug butyrate. These SLN inhibit the adhesion of polymorphonuclear cells to the endothelium and may act as anti-inflammatory agents. As cancer cell adhesion
Zhen Huang et al.
International journal of pharmaceutics, 397(1-2), 130-135 (2010-07-27)
Evidences indicating the presence of phase transformations in the mixed cholesteryl benzoate (CBE) and cholesteryl butyrate (CBU) under the supercritical CO(2) pressurization, by means of differential scanning calorimetry (DSC) and X-ray diffraction (XRD), are presented in this work. These include
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service